Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMOFlipid for Prevention of PNALD Progression in Infants
NCT00793195Phase 2Unknown
- Sponsor
- SickKids
- Start
- Jan 2009
- Primary completion
- Sep 2011
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SMOFlipid in Parenteral Nutrition Associated Liver Disease (PNALD) (2 arms), sponsored by SickKids. Primary endpoint: Mean serum conjugated bilirubin at 12 weeks. Status: unknown.
02
Drugs
SMOFlipid
03
Conditions
Parenteral Nutrition Associated Liver Disease (PNALD)
Beyond the preview
Go deeper on NCT00793195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00793195.